| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $61.9M | +40.6% |
| Cost of Revenue | $34.7M | +31.8% |
| Gross Profit | $27.2M | +53.7% |
| R&D Expense | $2.7M | +7.1% |
| SG&A Expense | $4.4M | +12.7% |
| Operating Income | $4.0M | +234.6% |
| Pre-tax Income | $4.4M | +263.0% |
| Income Tax | $1.1M | +329.0% |
| Net Income | $3.3M | +248.0% |
| EPS (Basic) | $0.53 | +251.4% |
| EPS (Diluted) | $0.51 | +250.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.0M | +5.0% |
| Accounts Receivable | $7.9M | +23.3% |
| Inventory | $20.9M | +16.2% |
| Current Assets | $47.6M | +15.6% |
| Total Assets | $52.0M | +12.0% |
| Current Liabilities | $9.8M | +23.5% |
| Long-term Debt | $2K | -94.1% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.8M | -35.3% |
| Investing Cash Flow | -$1.1M | +14.3% |
| Financing Cash Flow | -$218K | +57.7% |
| $9.8M |
| +19.3% |
| Stockholders' Equity | $42.2M | +10.4% |